NCT00508534 A Study To Evaluate The Effects Of Repeat Dosing Of Esomeprazole On The Pharmacokinetics Of SB-751689 In Healthy People Status COMPLETED Phase PHASE1
NCT00504166 Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women Status COMPLETED Phase PHASE4
NCT00503399 Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced Osteoporosis Status COMPLETED Phase PHASE3
NCT00500409 Safety and Efficacy of OSTEOFORM (rhPTH [1-34]) in Increasing Bone Mineral Density in Osteoporosis Status COMPLETED Phase PHASE3
NCT00499928 A Study To Investigate The Metabolism And Excretion Of 14C SB-751689 Given To Healthy Males And Postmenopausal Women Status COMPLETED Phase PHASE1
NCT00497458 Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects Status UNKNOWN Phase PHASE2
NCT00493623 BONDIR Study: A Study of Intravenous Bonviva (Ibandronate) After Recent Vertebral Osteoporotic Fracture in Patients With Osteoporosis. Status COMPLETED Phase PHASE3
NCT00489918 Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis Status COMPLETED Phase PHASE2
NCT00489424 Acetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an Intravenous (i.v.) Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-menopausal Women With Low Bone Mass Status COMPLETED Phase PHASE4
NCT00485953 Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy Status COMPLETED Phase PHASE4
NCT00481169 Study Evaluating TSE-424/Placebo/Raloxifene in Preventing Osteoporosis in Postmenopausal Women Status COMPLETED Phase PHASE3
NCT00480766 A Research Study to Evaluate the Safety and Effectiveness of MK0217 to Prevent and Treat Bone Loss (0217-193)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00479037 Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM) Status COMPLETED Phase PHASE4
NCT00471237 A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis. Status TERMINATED Phase PHASE2
NCT00468689 Evaluation Of SB-751689 Administered At Supratherapeutic Dose Levels In Healthy Adult Subjects. Status COMPLETED Phase PHASE1